Origen Financial ORGN 深 沪
等待开盘 09-18 09:30:00 美东时间
0.52
-0.001
-0.25%
华盛通- 最 高0.5357
- 今 开0.53
- 成交量 41.37万股
- 最 低 0.5183
- 昨 收 0.5213
- 总市值 7800.00万
- 52周最高 1.625
- 市盈率 静 --
- 换手率 0.28%
- 52周最低 0.4001
- 委 比 14.72%
- 总股本 1.50亿
- 历史最高 14.01
- 量 比 0.65
- 振 幅 3.34%
- 历史最低 0.4001
- 每 手 1
- 风险率 0.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Shares of KULR Technology Group, Inc. (NYSE:KULR) rose sharply in pre-market tr...
08-15 20:46
Origin Materials files $100M mixed securities shelf
Origin Materials (NASDAQ:ORGN) filed a $100 million mixed securities shelf on Thursday. Filing More on Origin Materials Origin Materials, Inc. 2025 Q2 - Results - Earnings Call Presentation Origin Ma...
08-15 15:07
Origin Materials Lowers FY2027 Sales Guidance from $150.000M-$210.000M to $100.000M-$200.000M
Origin Materials (NASDAQ:ORGN) lowers FY2027 sales outlook from $150.000 million-$210.000 million to $100.000 million-$200.000 million.
08-15 05:09
Origin Materials Announces The First Origin Pet Caps In Stores
Origin Materials, Inc. ("Origin") (NASDAQ:ORGN, ORGNW))), today announced the first Origin PET caps in stores. Origin partnered with Power Hydration, a new alkaline beverage brand, for the initial release of the
08-15 04:27
Origin Mat Q2 EPS $(0.09) Up From $(0.14) YoY, Sales $5.81M Down From $7.03M YoY
Origin Mat (NASDAQ:ORGN) reported quarterly losses of $(0.09) per share. This is a 35.71 percent increase over losses of $(0.14) per share from the same period last year. The company reported $5.81 million in sales this
08-15 04:21
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial
Oragenics, Inc. has selected Southern Star Research as its CRO for the Phase IIa clinical trial of ONP-002, a drug candidate for concussions. Southern Star’s expertise in early-phase trials and operational capabilities will support the randomized, double-blind, placebo-controlled study in adults with mild traumatic brain injury (mTBI). The partnership aims to advance the program efficiently and cost-effectively, leveraging Southern Star’s regiona...
07-31 12:30
Origen Resources Unveils 2025 Exploration Plans and Announces Financing
Origen Resources ( ($TSE:ORGN) ) has provided an update. Origen Resources Inc. ...
07-24 02:02
SpaceX gives a ride to rival Amazon's Kuiper satellite project
What would you think if one of your main competitors gave you a helping hand in getting ahead in the space race? That's precisely what just happened in the old rivalry between Elon Musk and Jeff Bezos...
07-16 18:53
